LEF1 Blocking PeptideProduct information
|100 µg||-||Unavailable in your region|
Product Pathways - Development
LEF1 Blocking Peptide #1016
|1016S||100 µg||---||In Stock||---|
|1016||carrier free and custom formulation / quantity||email request|
This product is assembled upon order. Please allow up to three weeks for your product to be processed.
This peptide is used to block LEF1 (C12A5) Rabbit mAb #2230 reactivity in dot blot protocols.
The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry. The peptide blocks LEF1 (C12A5) Rabbit mAb #2230 by dot blot.
Directions For Use
Use as a blocking reagent to evaluate the specificity of antibody reactivity in dot blot protocols.
LEF1 and TCF are members of the high mobility group (HMG) DNA binding protein family of transcription factors that consists of the following: Lymphoid Enhancer Factor 1 (LEF1), T Cell Factor 1 (TCF1/TCF7), TCF3/TCF7L1, and TCF4/TCF7L2 (1). LEF1 and TCF1/TCF7 were originally identified as important factors regulating early lymphoid development (2) and act downstream in Wnt signaling. LEF1 and TCF bind to Wnt response elements to provide docking sites for β-catenin, which translocates to the nucleus to promote the transcription of target genes upon activation of Wnt signaling (3). LEF1 and TCF are dynamically expressed during development and aberrant activation of the Wnt signaling pathway is involved in many types of cancers including colon cancer (4,5).
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
This product is intended for research purposes only. The product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.